First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease

AIM: To compare the one-week clinical effects of single doses of dexlansoprazole and esomeprazole on grades A and B erosive esophagitis. METHODS: We enrolled 175 adult patients with gastroesophageal reflux disease (GERD). The patients were randomized in a 1:1 ratio into two sequence groups to define...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Chih-Ming, Kuo, Ming-Te, Hsu, Pin-I, Kuo, Chao-Hung, Tai, Wei-Chen, Yang, Shih-Cheng, Wu, Keng-Liang, Wang, Hsing-Ming, Yao, Chih-Chien, Tsai, Cheng-En, Wang, Yao-Kuang, Wang, Jiunn-Wei, Huang, Chih-Fang, Wu, Deng-Chyang, Chuah, Seng-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743510/
https://www.ncbi.nlm.nih.gov/pubmed/29307999
http://dx.doi.org/10.3748/wjg.v23.i47.8395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743510/
https://www.ncbi.nlm.nih.gov/pubmed/29307999
http://dx.doi.org/10.3748/wjg.v23.i47.8395

Ejemplares similares